MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20

The present invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA encoding said antibody, the corresponding expression vectors and methods of production thereof, as well as methods of treatment using said antibody.

Saved in:
Bibliographic Details
Main Authors TRUDOVISHNIKOVA, Anna Alexandrovna, USATOVA, Veronika Sergeevna, KOSKOVA, Svetlana Vladimirovna, USTIUGOV, Iakov Iurevich, PESTOVA, Natalia Eugenievna, MISORIN, Alexey Konstantinovich, SOLOVYEV, Valery Vladimirovich, EROSHOVA, Anna Vladimirovna, DIDUK, Sergei Vasilyevich, ANIKINA, Arina Vitalevna, SHELEVA, Mariia Aleksandrovna, KHARATIAN, Nina Grachyaevna, IAKOVLEV, Pavel Andreevich, KRENDELEVA, Elena Andreevna, MOROZOV, Dmitry Valentinovich, ALEKSANDROV, Aleksei Aleksandrovich, IVANOV, Roman Alekseevich, SMIRNOVA, Iana Andreevna
Format Patent
LanguageEnglish
Published 24.03.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA encoding said antibody, the corresponding expression vectors and methods of production thereof, as well as methods of treatment using said antibody.
Bibliography:Application Number: US201917288234